Premixed Injectable MTA for Pulpotomy of Primary Teeth
Not yet recruiting
- Conditions
- Dental caries indicated for Pulpotomy without irreversible pulpal damagePulpitis,
- Registration Number
- CTRI/2023/07/055519
- Lead Sponsor
- AISWARYA U S
- Brief Summary
Pulpotomy is vital endodontic procedure done to maintain the integrity of the radicular pulp. This study will be done to evaluate the clinical and radiographic outcome of Premixed Injectable MTA and Conventional MTA as pulpotomy medicament in primary teeth.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Not Yet Recruiting
- Sex
- All
- Target Recruitment
- 15
Inclusion Criteria
Children with bilateral indication for pulpotomy without signs and symptoms of irreversible pulpal damage.
Exclusion Criteria
Children with irreversible pulpal damage, sinus or fistula and children with systemic diseases.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Injecatble form of MTA can be used as a Pulpotomy Medicament in Primary teeth. Clinical and radiographic assessment will be done. Over a period of 6 months and one year
- Secondary Outcome Measures
Name Time Method Clinical & radiographic outcome of the pulpotomy with premixed injectable MTA will be assessed over a follow up period 12 months
Trial Locations
- Locations (1)
Yenepoya Dental College
🇮🇳Kannada, KARNATAKA, India
Yenepoya Dental College🇮🇳Kannada, KARNATAKA, IndiaDr Aiswarya U SPrincipal investigator8220083144aishuaish59@gmail.com